Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetyl-CoA carboxylase (ACCase) is a vital enzyme that catalyzes the first committed and rate-limiting step in fatty acid biosynthesis, specifically the ATP-dependent carboxylation of acetyl-CoA to form malonyl-CoA (Sasaki & Nagano, 2004). In plants, the homomeric form of ACCase is a large, multifunctional polypeptide located in the cytosol of all plants and within the plastids of the Poaceae (grass) family (Délye, 2005). The carboxyltransferase (CT) domain of this homomeric enzyme serves as the specific molecular target for three major classes of herbicides: aryloxyphenoxypropionates (FOPs), cyclohexanediones (DIMs), and phenylpyrazolines (DENs) (Incledon & Hall, 1997). These herbicides, collectively known as graminicides, bind to the CT domain and prevent the transfer of the carboxyl group from biotin to acetyl-CoA (HRAC, 2024). This action depletes the pool of malonyl-CoA, halting the production of essential fatty acids and leading to the collapse of cell membranes and plant death (Sasaki & Nagano, 2004). The selectivity of these herbicides arises because most dicotyledonous plants utilize a herbicide-insensitive heteromeric ACCase in their plastids (Délye, 2005). However, the efficacy of these treatments is increasingly challenged by the emergence of herbicide-resistant weed populations, often driven by specific point mutations within the CT domain that disrupt drug binding (Délye, 2005).
Inhibition of the carboxyltransferase activity of the homomeric acetyl-CoA carboxylase enzyme, preventing the conversion of acetyl-CoA to malonyl-CoA and thereby halting de novo fatty acid biosynthesis.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetyl-CoA carboxylase (ACCase), carboxyltransferase domain (plant homomeric) (ACCase-CT).